Literature DB >> 3146719

Reduction of blood pressure retards the progression of chronic renal failure in man.

A Alvestrand1, A Gutierrez, H Bucht, J Bergström.   

Abstract

The effect of blood pressure reduction on the progression rate of chronic renal failure (CRF) was studied in 28 patients with CRF of diverse aetiology entering a prospective study (observation time 7-24 months, mean 16 months). Endogenous creatinine clearance was 12-66 ml/min (mean 30 +/- 3 ml/min). We aimed to keep the blood pressure below 160/90 mmHg. Dietary protein was not restricted. The progression rate of CRF was assessed from the regression coefficients of the regressions of creatinine clearance and the inverse of s-creatinine, respectively, on time. Progression rate and the means of all recordings of mean arterial blood pressure (MAP) and urinary protein excretion, respectively, in each patient during the prospective phase were compared with retrospective data from the proceeding period (observation time 4-25 months, mean 19 months). The patients received various combinations of antihypertensive drugs including diuretics, beta-blockers and vasodilatory drugs. In 19 patients MAP decreased from 109 +/- 2 to 102 +/- 2 mmHg (group I), whereas MAP increased from 105 +/- 2 to 108 +/- 2 mmHg in nine patients (group II). In group I proteinuria was significantly lower (P less than 0.05) and the progression of CRF was approximately 50% slower (P less than 0.01) in the prospective phase than in the retrospective phase; no changes were observed in group II. Calculated for all patients, significant correlations were observed between the change in MAP and the change in progression rate and protein excretion, respectively. These results indicate that lowering of blood pressure results in decreased proteinuria and retardation of the progression of CRF irrespective of the aetiology.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146719     DOI: 10.1093/oxfordjournals.ndt.a091717

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  The effects of low dose intravenous 99-126 atrial natriuretic factor infusion in patients with chronic renal failure.

Authors:  A S Woolf; M A Mansell; B I Hoffbrand; S L Cohen; P J Moult
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

Review 2.  Angiotensin-converting enzyme inhibitors in chronic renal failure.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Effect of antihypertensive drugs on glomerular hyperfiltration and renal haemodynamics. Comparison of captopril with nifedipine, metoprolol and celiprolol.

Authors:  J Böhler; A Becker; P Reetze-Bonorden; R Woitas; E Keller; P Schollmeyer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Angiotensin converting enzyme (ACE) inhibitors and renal function. A review of the current status.

Authors:  A L Kamper
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

5.  Follow-up of renal function and urinary protein excretion in childhood IgA nephropathy.

Authors:  U B Berg; U C Widstam-Attorps
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

6.  Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure.

Authors:  T Hannedouche; P Landais; B Goldfarb; N el Esper; A Fournier; M Godin; D Durand; J Chanard; F Mignon; J M Suo
Journal:  BMJ       Date:  1994-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.